These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2828442)

  • 1. Vaccines for latent viruses.
    Pass F
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):224-6. PubMed ID: 2828442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for vaccines for herpes simplex viruses.
    Berman PW
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):226-30. PubMed ID: 2828443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization against bovine papillomavirus infection.
    Pilacinski WP; Glassman DL; Glassman KF; Reed DE; Lum MA; Marshall RF; Muscoplat CC; Faras AJ
    Ciba Found Symp; 1986; 120():136-56. PubMed ID: 3013520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against papillomavirus in cattle.
    Campo MS
    Clin Dermatol; 1997; 15(2):275-83. PubMed ID: 9167911
    [No Abstract]   [Full Text] [Related]  

  • 5. Papillomaviruses: progress for human and veterinary medicine.
    Onions D
    Vet J; 1997 Nov; 154(3):171-2. PubMed ID: 9414949
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination against papillomavirus in cattle.
    Campo MS
    Curr Top Microbiol Immunol; 1994; 186():255-66. PubMed ID: 8205844
    [No Abstract]   [Full Text] [Related]  

  • 7. Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases.
    Harasawa R
    Vaccine; 1995 Jan; 13(1):100-3. PubMed ID: 7762264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against cutaneous and mucosal papillomavirus in cattle.
    Campo MS; Jarrett WF
    Ciba Found Symp; 1994; 187():61-73; discussion 73-7. PubMed ID: 7796677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against herpesvirus, fiction or reality?
    Morein B; Merza M
    Scand J Infect Dis Suppl; 1991; 80():110-8. PubMed ID: 1666442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of thymidine kinase activity in a potential bovine herpesvirus 2 vaccine does not increase its virulence.
    Paxman JJ; Enriquez AM; May JT
    Acta Virol; 2000 Feb; 44(1):57-9. PubMed ID: 10989694
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.
    Cremer KJ; Mackett M; Wohlenberg C; Notkins AL; Moss B
    Science; 1985 May; 228(4700):737-40. PubMed ID: 2986288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic value of partial excision of lesions combined with administration of an autogenous vaccine during an episode of cutaneous papillomatosis in cattle of Uganda.
    Ssenyonga GS; Onapito JS; Nakasala-Situma J; Omara-Opyene AL
    J Am Vet Med Assoc; 1990 Sep; 197(6):739-40. PubMed ID: 2170314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.
    Kirnbauer R; Chandrachud LM; O'Neil BW; Wagner ER; Grindlay GJ; Armstrong A; McGarvie GM; Schiller JT; Lowy DR; Campo MS
    Virology; 1996 May; 219(1):37-44. PubMed ID: 8623552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
    Weinberg A; Merigan TC
    J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic and therapeutic vaccination against a mucosal papillomavirus.
    Campo MS; Grindlay GJ; O'Neil BW; Chandrachud LM; McGarvie GM; Jarrett WF
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():945-53. PubMed ID: 8389809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant DNA technology for the preparation of subunit vaccines.
    Bachrach HL
    J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies.
    Gaukroger JM; Chandrachud LM; O'Neil BW; Grindlay GJ; Knowles G; Campo MS
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1577-83. PubMed ID: 8758002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
    Morgan DO; Moore DM
    Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.